[{"address1": "Modi\u2019in Technology Park", "address2": "2 HaMa\u2019ayan Street", "city": "Hevel Modi'in", "zip": "7177871", "country": "Israel", "phone": "972 8 642 9100", "fax": "972 8 642 9101", "website": "https://www.biolinerx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "BioLineRx Ltd., a commercial stage biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company's pipeline includes APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the treatment of pancreatic cancer, as well as completed Phase 3 clinical trial for the treatment of multiple myeloma. It also develops BL-5010, a pen-like applicator containing an acidic aqueous solution for the non-surgical removal of skin lesions. BioLineRx Ltd. was incorporated in 2003 and is headquartered in Hevel Modi'in, Israel.", "fullTimeEmployees": 79, "companyOfficers": [{"maxAge": 1, "name": "Mr. Philip A. Serlin CPA, M.B.A., CPA, MBA", "age": 64, "title": "Chief Executive Officer", "yearBorn": 1960, "fiscalYear": 2023, "totalPay": 598000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Mali  Zeevi CPA, CPA", "age": 48, "title": "Chief Financial Officer", "yearBorn": 1976, "fiscalYear": 2023, "totalPay": 374000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Ella  Sorani Ph.D.", "age": 56, "title": "Chief Development Officer", "yearBorn": 1968, "fiscalYear": 2023, "totalPay": 452000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John  Lacey", "title": "Head of Corporate Communications & Investor Relations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Tsipi  Keren-Lehrer B.Sc., L.L.B.", "title": "Head of BD & Strategic Advisor", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Raziel  Fried", "title": "Treasurer & Budgetary Control Director", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 3.51, "open": 3.51, "dayLow": 3.44, "dayHigh": 3.86, "regularMarketPreviousClose": 3.51, "regularMarketOpen": 3.51, "regularMarketDayLow": 3.44, "regularMarketDayHigh": 3.86, "beta": 0.99, "forwardPE": -0.8431818, "volume": 99824, "regularMarketVolume": 99824, "averageVolume": 230463, "averageVolume10days": 119960, "averageDailyVolume10Day": 119960, "ask": 3.89, "askSize": 200, "marketCap": 13202035, "fiftyTwoWeekLow": 3.2, "fiftyTwoWeekHigh": 57.6, "priceToSalesTrailing12Months": 0.6003381, "fiftyDayAverage": 6.6362, "twoHundredDayAverage": 19.84305, "currency": "USD", "enterpriseValue": 4451921408, "profitMargins": -0.90573, "floatShares": 1142506606, "sharesOutstanding": 3558500, "sharesShort": 122863, "sharesShortPriorMonth": 20555, "sharesShortPreviousMonthDate": 1735603200, "dateShortInterest": 1738281600, "sharesPercentSharesOut": 0.0345, "heldPercentInsiders": 0.04675, "heldPercentInstitutions": 0.015140001, "shortRatio": 0.23, "shortPercentOfFloat": 0.0375, "impliedSharesOutstanding": 75170304, "bookValue": 0.007, "priceToBook": 530.0, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -19918000, "trailingEps": -12.0, "forwardEps": -0.22, "lastSplitFactor": "1:40", "lastSplitDate": 1738195200, "enterpriseToRevenue": 202.443, "enterpriseToEbitda": -174.647, "52WeekChange": -0.9274793, "SandP52WeekChange": 0.22903383, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "BLRX", "underlyingSymbol": "BLRX", "shortName": "BioLineRx Ltd.", "longName": "BioLineRx Ltd.", "firstTradeDateEpochUtc": 1311773400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "e62a36f1-05bb-3c53-9aee-d33adfbdf394", "messageBoardId": "finmb_5015080", "gmtOffSetMilliseconds": -18000000, "currentPrice": 3.71, "targetHighPrice": 360.0, "targetLowPrice": 80.0, "targetMeanPrice": 182.66667, "targetMedianPrice": 108.0, "recommendationKey": "none", "numberOfAnalystOpinions": 3, "totalCash": 29173000, "totalCashPerShare": 0.024, "ebitda": -25491000, "totalDebt": 29614000, "quickRatio": 1.327, "currentRatio": 1.516, "totalRevenue": 21991000, "debtToEquity": 348.195, "revenuePerShare": 11.4, "returnOnAssets": -0.32961, "returnOnEquity": -1.84094, "grossProfits": 15125000, "freeCashflow": -16981376, "operatingCashflow": -30272000, "grossMargins": 0.68778, "ebitdaMargins": -1.15916, "operatingMargins": -1.08982, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2025-02-15"}]